Arrowhead Pharmaceuticals, Inc. (ARWR) stock
ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$47.78+0.63 (+1.34%)
Close on Nov 13, 2026Market cap $6.75BP/E –Yield –
Arrowhead Pharmaceuticals statistics
82 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 4, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 149.48
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 12.33
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 5.89%
- 10.8%
- Shares Change (QoQ)
- 0.11%
- 0.50%
- Float
- 136M
- 49M
- Shares Held by Insiders
- 4.03%
- 11.7%
- Shares Held by Institutions
- 84.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 12M
- –
- Short Interest Change
- 5.70%
- -0.80%
- Short % of Float
- 8.54%
- 9.01%
- Short % of Shares Outstanding
- 8.20%
- 6.30%
- Days to Cover
- 8.54
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $95.49
- –
- 52-Week Low
- $37.06
- –
- 20-Day Moving Average
- $56.44
- –
- 50-Day Moving Average
- $63.32
- –
- 200-Day Moving Average
- $71.09
- –
- Average True Range (14)
- $3.07
- –
- Price Change (1 Week)
- -17.8%
- -1.15%
- Price Change (1 Month)
- -18.3%
- -4.87%
- Price Change (3 Months)
- -46.1%
- -21.0%
- Price Change (6 Months)
- -37.7%
- -20.6%
- Price Change (YTD)
- -28.0%
- -23.6%
- Price Change (1 Year)
- 15.4%
- -22.4%
- Price Change (3 Years)
- 74.4%
- -29.5%
- Price Change (5 Years)
- -35.4%
- -77.9%
- Price Change (10 Years)
- 981.0%
- -65.4%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 1.61
- 0.70
- Relative Strength Index (14)
- 25.9
- 43.4
- Volatility (1 Year)
- 63.0%
- 80.1%
- Beta (5 Years)
- 1.68
- 1.07
MarginsIndustry
- Pretax Margin
- -160.6%
- -11.6%
- EBITDA Margin
- -151.4%
- -27.7%
- FCF Margin
- -63.0%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -280.5%
- -49.9%
- Return on Assets (ROA)
- -46.4%
- -40.6%
- Return on Capital Employed (ROCE)
- -49.6%
- -37.9%
Financial positionIndustry
- Current Ratio
- 4.14
- 3.30
- Quick Ratio
- 3.86
- 2.39
- Interest Coverage
- -7.55
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- -45.6%
- 6.82%
- FCF Growth (YoY)
- -281.0%
- 6.85%
- Revenue Growth (3Y CAGR)
- 23.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- 26.7%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.29
- 0.40
- Revenue Per Employee
- $634.06K
- $429.29K
- Profits Per Employee
- -$1.02M
- -$689.41K
- Employee Count
- 711
- 74
- WACC
- 13.5%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$723.92M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $1.19B
- $17.76M
- Net Cash Per Share
- $8.45
- $0.80
- Equity (Book Value)
- $50.31M
- $53.89M
- Book Value Per Share
- $0.36
- $1.50
- Tangible Book Value
- $45.15M
- $27.13M
- Working Capital
- $977.88M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$12.00M
- -$1.00M
- FCF Per Share
- -$2.01
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -10.7%
- -21.8%
- FCF Yield
- -4.21%
- -9.44%
Taxes and interestIndustry
- Interest Expense
- $93.71M
- $2.90M
- Income Tax
- -$6.78M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 0.10
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | ARWR | S&P 500 | Difference | ARWR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.8% | -3.0% | −14.8 pts | ||
| 3 months | -44.2% | -2.8% | −41.4 pts | ||
| Year to date | -28.0% | +11.5% | −39.5 pts | ||
| 1 year | +16.1% | +13.5% | +2.7 pts | ||
| 3 years | +84.0% | +77.7% | +6.3 pts | +22.5% | +21.1% |
| 5 years | -35.4% | +72.6% | −108.0 pts | -8.4% | +11.5% |
| 10 years | +1043.1% | +308.2% | +734.9 pts | +27.6% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
12M ARWR shares were sold short on Oct 30, 2026, up 5.7% from the previous report, or 8.54% of the shares available to trade. At recent volumes it would take 8.5 days to buy them back. Over the last 20 sessions, 50.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 11,583,518 | +5.7% | 1,355,859 | 8.5 |
| Oct 15, 2026 | 10,959,276 | +1.8% | 2,046,319 | 5.4 |
| Sep 30, 2026 | 10,760,463 | +16.0% | 2,669,000 | 4.0 |
| Sep 15, 2026 | 9,272,290 | -1.6% | 1,800,675 | 5.2 |
| Aug 31, 2026 | 9,426,449 | +2.4% | 1,069,411 | 8.8 |
| Aug 14, 2026 | 9,207,426 | -4.6% | 1,178,174 | 7.8 |
| Jul 31, 2026 | 9,656,078 | +0.2% | 2,505,740 | 3.9 |
| Jul 15, 2026 | 9,635,297 | +14.3% | 1,983,559 | 4.9 |
| Jun 30, 2026 | 8,430,780 | -28.2% | 3,819,505 | 2.2 |
| Jun 15, 2026 | 11,738,844 | -5.3% | 1,434,379 | 8.2 |
| May 29, 2026 | 12,391,532 | -4.1% | 1,493,389 | 8.3 |
| May 15, 2026 | 12,925,632 | -0.1% | 1,844,498 | 7.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?